The death mediator caspase acts as the dominant regulator during cell death induction. The CPP32 subfamily, including caspase 3 (CPP32/Yama/Apopain), is essential for the cell death signaling. We recently reported that activation of caspase 3 is regulated by complex formation with p21 or ILP. In the present study, we investigated the binding domain with p21 and ILP to further characterize the caspase 3 inactivation machinery. Our results show that caspase 3 contains p21 binding domain in the N-terminus and ILP binding domain in the active site. Further, the caspase 3 binding domain in p21 was independent of the Cdk-or PCNAbinding domain. We also found caspase 3 protection by p21 from the p3-site cleavage serineproteinase contributes to the suppression machinery. Here, we propose the caspase 3 inactivation system by p21 and ILP as new essential system in the regulation of cell death.
Introduction
Apoptotic cell death accompanied by the apoptotic body formation and chromosomal DNA fragmentation into 180 bp oligomers is an essential phenomenon for cell homeostasis as well as cell growth (Wyllie et al., 1980; Nagata, 1997) . Recent multiple studies have demonstrated the important role of apoptotic cell death in various disease states and physiological cell death (Nagata and Golstein, 1995) and many factors involved with the death signaling have been identi®ed.
Death receptor Fas transduces the death signaling upon stimulation by Fas ligand or an agonistic Fas antibody (Nagata and Golstein, 1995) , such as the CH-11 clone (Yonehara et al., 1989) . The molecular mechanism of Fas-mediated apoptosis has been extensively investigated. Caspase is the nomenclature that refers to the interleukin-1b converting enzyme (ICE)/CED-3 cysteineproteinase family . Three subfamilies have been identi®ed, known as the ICE subfamily, CPP32 subfamily and ICH-1 subfamily. At present, ten genes have been identi®ed as caspase, and the CPP32 subfamily, including caspase 3 (CPP32/Yama/Apopain and refs. Fernandes-Alnemri et al., 1994; Nicholson et al., 1995) and caspase 8 (FLICE/MACH and refs. Boldin et al., 1996; Muzio et al., 1996) , in particular acts as the dominant regulator in the death signaling. Therefore, the regulation of CPP32 subfamily activation is an especially important focus for cell death research.
For the activation machinery, we have reported a two step system: the sequential proteolysis of caspase 3 by a cytoplasmic serineproteinase (p3 site-cleavage serineproteinase) and CPP32 subfamily (p17 site cleavage) (Suzuki et al., 1997b) . In addition, we also reported the suppression machinery of caspase 3: cell cycle regulator p21 interacts with procaspase 3 and IAP gene family ILP interacts with activated caspase 3 (Suzuki et al., 1998) .
Thus, activation of caspase 3 is regulated by both p21 and ILP (Suzuki et al., 1998) . In the present study, we investigated the binding domain with p21 and ILP to further characterize the caspase 3 inactivation machinery.
Results

Identi®cation of the caspase 3 binding domain in p21
We have previously demonstrated that p21 and ILP interact with caspase 3 (Suzuki et al., 1998) . p21 interacts with procaspase 3 and ILP interacts with activated caspase 3. To further investigate procaspase 3/p21 complex formation, we probed for the binding site using Far-Western blotting. When GST-p21 was incubated with lysyl endopeptidase (Achromobacter protease I: EC3.4.21.50), three fragments (about 7.5 K, 4 K, 1.8-1.4 K) were separated by Tricine-SDS ± PAGE and detected by Western blotting using p21 antibody ( Figure 1a ). Far-Western blotting analysis of a similar p21 digest with biotin-procaspase 3 indicated that at least the 4 K p21-fragment bound procaspase 3 ( Figure  1b ). In contrast, neither GST nor digested GST interacted with the biotin-procaspase 3 (Figure 1b) . These results suggest that the 4 K fragment contains caspase 3 binding domain (Figure 1c ).
Identi®cation of p21 or ILP binding domain in caspase 3
Human hepatoma HepG2 cells show Fas-mediated apoptosis initiated by caspase 3 in the presence of actinomycin D de novo protein synthesis inhibitor (transcriptional inhibitor) (Hasegawa et al., 1996; Suzuki et al., 1998) . When HepG2 cells were reacted with agonistic human Fas antibody (Fas Ab: CH-11 clone and ref. Yonehara et al., 1989) , changes in migration of procaspase 3 antigen (32 K/29 K/17 K) was observed by Western blotting (Figure 2a ). FarWestern blotting with biotin-GST-p21 showed binding only to the 32 K. A similar analysis with biotin-GST-ILP showed binding to the 17 K caspase 3 fragment. These results are consistent with our previous observations (Suzuki et al., 1998) . In contrast, GST did not interact with caspase 3 or its fragments ( Figure  2a ). These results suggest that caspase 3 contains p21 binding domain in N-terminal region and ILP binding domain near the active site (Figure 2b ).
Death suppression by the p21-derived 4 K fragment
Our present results shown in Figure 1 strongly suggest that 4 K-p21 fragment contains caspase 3 binding domain. Therefore, the eect of fragmented p21 in Fasmediated apoptosis was investigated by nuclear morphological analysis using Hoechst 33342/PI staining. When full length p21 was loaded into HepG2 cells, resistance to Fas-mediated apoptosis was encountered. In contrast, cells loaded full length GST-or all fragmented GST did not show this resistance. Cells loaded with either all fragments (7.5 K+4 K+1.8-1.4 K) or only the 4 K fragment also showed the resistance. However, 7.5 K-or 1.8-1.4 K-fragment was insucient to change resistance on the cells ( Figure  3a ). In addition, binding ability was also examined to further support our demonstration that 4 K fragment contains caspase 3 binding domain. After loading of each fragmented p21, immunoprecipitates with caspase 3 antibody were separated on Tricine-SDS ± PAGE. As shown in Figure 3b , only 4 K fragment was coimmunoprecipitated with caspase 3.
Molecular machinery of death suppression by p21
Our present results demonstrated that the 4 K fragment of p21 interacted with procaspase 3. To (a) Peptide mapping of GST-p21. GST-p21 was digested with lysyl endopeptidase (5 units/mM GST-p21 for 4 h at 378C). After digestion, proteins were separated on Tricine SDS ± PAGE (16.5% T/ 3% C) and transferred onto PVDF membrane. Peptides as a result of GST-p21 digestion were detected by Western blotting with anti-human p21 antibody. Color development was performed with the ECL system. Arrows show the positions of GST-p21 peptides (7.5 K, 4 K and 1.8-1.4 K: from head to bottom). (b) Far-Western blotting analysis with caspase 3. GST-p21 and GST were digested with lysyl endopeptidase, separated on Tricine SDS ± PAGE and transferred to a PVDF membrane as described above. Procaspase 3 which was puri®ed by immunoprecipitation and electroelution procedure was biotinylated and reacted with digested GST-p21 or GST. Biotinylated procaspase 3-binding peptide was detected with avidin-horseradish peroxidase and the ECL system. Arrows show the positions of fragmented GST-p21 (7.5 K, 4 K and 1.8-1.4 K: from head to bottom). (c) Molecular structure of p21. The Cdk2-binding domain at residues 49-71 (Cdk2) and the PCNA-binding domain at residues 76-164 (PCNA) have been reported. Our present study identi®ed the caspase 3 binding domain in p21 within the 15-33 amino acid region. Closed box show the regions of functional domain further elucidate the molecular machinery of the death suppression by p21, enzymatic activity was tested. During Fas-mediated apoptosis in HepG2 cells, the cleavage of DEVD-MCA (Hasegawa et al., 1996) , ESMD-MCA (Suzuki et al., 1997b) and IETD-MCA (Suzuki et al., 1997b) can be detected. When full length p21 or its 4 K fragment was loaded into HepG2 cells, ESMD-MCA and IETD-MCA cleavage was encountered, but DEVD-MCA cleavage was not observed (Figure 4 ). These results suggest the possible involvement of p21 in the proteolysis of caspase 3.
Necessity of the procaspase 3 cleavage at p3 site in Fas-mediated apoptosis Previously, we demonstrated sequential proteolysis of procaspase 3 at the p3 and p17 sites (Suzuki et al., 1997b) . Our results now suggest the possibility that p21 regulates this procaspase 3 cleavage. As the ®rst step of caspase 3 activation, procaspase 3 is proteolysed at the p3 site (Suzuki et al., 1997b) , and we prepared a p3 cleavage-serineproteinase (Suzuki et al., 1997b) tetrapeptide inhibitor, ESMD-CHO. When HepG2 cells were reacted with Fas Ab in the presence of actinomycin D, cell death was accompanied by nuclear condensation and/or fragmentation, ESMD-MCA cleavage activity and DEVD-MCA cleavage activity ( Figure 5 ). However, these events were suppressed by the pretreatment with ESMD-CHO ( Figure 5 ). These results suggest the necessity of caspase 3 cleavage at the p3 site during Fas-mediated apoptosis.
Discussion
Apoptotic cell death is necessary for the cell homeostasis as well as cell growth and recent multiple studies revealed various cell death-associated genes. ICE/CED-3 cysteineproteinase family, caspase, regulates the cell death signaling , and death receptor Fas also initiates its activation (Nagata, 1997) . Recently, we reported caspase 3 activation was regulated by p21 and ILP (Suzuki et al., 1998) . In the present study, therefore, we investigated the binding domain and death-suppression machinery to further characterize the caspase 3 inactivation system by p21 and ILP.
First, we probed for the caspase 3 binding domain in p21. As shown in Figure 1 , three bands were detected from the lysyl endopeptidase digestion of GST-p21. We previously demonstrated that p21 interacted with only procaspase 3, but not with activated caspase 3 (Suzuki et al., 1998) , and procaspase 3 bound to 4 K p21-fragment in the present study. On the basis of the molecular weight and the theoretical digestion by the lysyl endopeptidase, we propose that this 4 K fragment is the N-terminal sequence (1 ± 33 amino acid). Since residues 1 ± 14 of the N-terminal region of p21 is the signal sequence, we suggest that the caspase 3 binding domain in p21 resides in the 15 ± 33 amino acid region. It is known that p21 is the cell cycle regulator (cell cycle arrest inducer) and interacts with Cdk (cyclindependent kinase) and PCNA (proliferating cell nuclear antigen) (Xiong et al., 1993; Li et al., 1994) . The Cdk-binding domain in p21 was identi®ed as the 49 ± 71 amino acid region (Nakanishi et al., 1995) and the PCNA-binding domain is found in the 76 ± 164 amino acid region (Chen et al., 1995; Luo et al., 1995) . Our present results demonstrated that the caspase 3 binding domain in p21 is most likely within the 15 ± 33 amino acid region, suggesting that the caspase 3 binding domain is not dependent on the Cdk2-or PCNA-binding domains. Thus, p21 suppresses Fasmediated apoptosis by binding to procaspase 3 and its suppression mechanism is independent of a requirement of p21 to inhibit cell cycle arrest induction.
We also investigated p21 or ILP binding domains in caspase 3. Caspase 3 activation during Fas-mediated apoptosis is suppressed by two distinct systems: Procaspase 3 is inactivated by p21 and activated caspase 3 is suppressed by ILP (Suzuki et al., 1998) . Therefore, caspase 3 contains p21 or ILP binding HepG2 cells loaded with various peptides (10 ng/ml) were reacted with 1 mg/ml Fas Ab in the presence of 0.5 mg/ml actinomycin D for 24 h. After reaction, the cell viability of each group was assessed by the Hoechst 33342/PI staining procedure as previously described (Hasegawa et al., 1996) with some modi®cations (Suzuki et al., 1997a,b) . Cell viability was indicated as the ratio of cells carrying intact nuclei to total cells (about 5000 cells). GST-p21: undigested GST-p21; GST: undigested GST; All p21; digested GST-p21 mixture; All GST: digested GST mixture; 7.5 K, 4 K and 1.8-1.4 K: p21-7.5 K, 74 K and 71.8 ± 1.4 K fragments produced by the lysyl endopeptidase treatment. Each fragment was collected by electroelution. (b) Co-immunoprecipitation analysis. All fragmented (Total), and each fragmented (7.5 k, 4 K or 1.8 ± 1.4 K) p21 were loaded into HepG2 cells, and then immunoprecipitation with caspase 3 antibody was performed. Immunoprecipitates were separated on Tricine-SDS ± PAGE and co-immunoprecipitates were detected with anti-human p21 antibody. Arrow shows the position of 4 K fragment Figure 4 Proteolytic activity of death-associated proteinases. HepG2 cells loaded with various peptides (same as Figure 3) were treated with Fas Ab, and proteins were collected for the measurement of death-associated proteinase activity. DEVD-MCA: substrate for caspase 3; IETD-MCA: substrate for the p17-site cleavage CPP32 subfamily; ESMD-MCA: substrate for the p3-site cleavage serineproteinase. Protein extraction and measurement of proteinase activity were performed as described previously (Hasegawa et al., 1996; Suzuki et al., 1997b) domain. In addition, we previously reported that caspase 3 activation results from sequential proteolysis at two sites during Fas-mediated apoptosis: The ®rst occurs at the p3 site (Asp 28; ESMD-SGIS) by a cytoplasmic serineproteinase and then at the p17 site (Asp 175; IETD-SGVD) by caspase 3 autolysis or by another member of the CPP32 subfamily (Suzuki et al., 1997b) . By stimulation with Fas Ab, we demonstrated three fragments of caspase 3. p32 corresponds to native procaspase 3, p29 is the proactivated form of caspase 3 induced resulting from p3 site-cleavage and p17 is the activated form of caspase 3 resulting from both p3-and p17-site cleavages. As shown in Figure 2 , p21 bound to procaspase 3 and ILP bound to activated caspase 3. The p29-caspase 3 fragment lacks the Nterminal sequence due to the p3 site-cleavage. Therefore, our present results suggest that the p21 binding domain in caspase 3 is contained in the N-terminal amino acid (1 ± 28 amino acid region). In addition, we and QL Deveraux, have reported that ILP can directly suppress the activation of caspase 3 (Deveraux et al., 1997; Suzuki et al., 1998) . Taken together, these observations (binding of ILP to p17-activated caspase 3) suggest that ILP interacts with the active site of caspase 3 and that the ILP binding domain is contained in p17-activated caspase 3 (residues 28 ± 175). ILP bound only to activated caspase 3, although p32 and p29 contain the binding domain. We suggest that this selective interaction is due to structural change in caspase 3 during death signaling. In some proteinases, like metalloproteinase MMP-2 (Gelatinase A), the active site is covered with other region of its protein self, such as N-terminus, and exposure of active site is induced by the proteolysis which is performed as the enzyme-activation (Miyazaki et al., 1992) . Before the death induction, the active site of caspase 3 may be also covered with other region, such as N-terminal region.
Thus, we identi®ed the binding domain in each factor. To further characterize it, we sought to gain insight into the molecular machinery of death suppression. Although the activated caspase 3/ILP complex is important for the inactivation of caspase 3, some interesting results, including our present ®ndings, have already been reported. We hypothesize the suppression machinery by ILP to be that ILP binds directly to active site of activated caspase 3. As a result of this binding, death substrates, such as poly (ADPribose) polymerase (PARP), lamin and caspaseactivated DNase (CAD), cannot interact with activated caspase 3 (Fernandes- Alnemri et al., 1994 Alnemri et al., , 1996 Tewari et al., 1995) .
To our knowledge, studies suggesting caspase 3 inactivation by p21 have not been reported. Therefore, we investigated the molecular mechanism of death suppression by p21. During Fas-mediated apoptosis, activation of caspase 3 results from proteolysis at two sites. This activation during Fas-mediated apoptosis is accompanied by the cleavage of ESMD-MCA (p3-site cleavage by serineproteinase) and IETD-MCA (p17-site cleavage by caspase 3 autolysis or another CPP32 subfamily member) (Suzuki et al., 1997b) . When full length p21 or the 4 K fragment containing the caspase 3 binding domain was loaded into cells, resistance to Fas-mediated apoptosis and the binding of 4 K fragment with caspase 3 were encountered even in the presence of caspase 3 activators. The binding domain for both p21 and caspase 3 is contained in their N-terminal regions. In caspase 3, this domain is near the p3 cleavage site. Since p3-site cleavage is a necessity for Fas-mediated apoptosis and the loading of the 4 K fragment of p21 protects the cells from Fas-mediated apoptosis even with the activation by the serineproteinase, p21 covers the p3 cleavage site of caspase 3 by binding each binding domain. By steric hindrance, then, the p3 site is inaccessible and the activated serineproteinase cannot proteolyse the caspase 3.
Materials and methods
Cell lines
Human hepatoma HepG2 cells were supplied by Dr Yoshihide Tsujimoto (Hasegawa et al., 1996) and were maintained in RPMI-1640 medium (Gibco ± BRL., MD, USA) supplemented with 10% heat-inactivated fetal calf Figure 5 Necessity of p3 site-cleavage during Fas-mediated apoptosis. Analysis of the death suppression by p21 showed the necessity of p3 site-cleavage of caspase 3. Therefore, we used the synthetic tetrapeptide inhibitor ESMD-CHO to investigate the necessity of p3 site-cleavage of caspase 3 during Fas-mediated apoptosis. HepG2 cells pretreated with (+) or without (7) 100 mM ESMD-CHO were reacted with 1 mg/ml Fas Ab in the presence of actinomycin D. After reaction, cell viability (a), p3-site cleavage serineproteinase activity (b) and caspase 3 activity (c) were measured serum (FCS; Gibco ± BRL) in a humidi®ed atmosphere of 5% CO 2 and 95% air.
Peptides and antibody
DEVD-MCA was purchased from Peptide Lab. (Osaka, Japan). ESMD-CHO was synthesized at Peptide Lab. ESMD-MCA and IETD-MCA were synthesized at Science Tanaka (Sapporo, Japan). As the agonistic Fas antibody (Fas Ab), the CH-11 clone was purchased from MBL Japan (Nagoya, Japan). Anti-human CPP32 antibody was purchased from Transduction Laboratory (Lexington, KY, USA).
Preparation of GST-p21
The plasmids encoding GST or the GST-murine p21 fusion protein were transformed into E. coli, and the proteins were puri®ed on glutathione Sepharose 4B (Pharmacia Biotech. AB). The pGST-p21 plasmid was provided by Dr Hitoshi Matsushime (Homan La-Roche, Inc., NJ, USA).
Preparation of cell extracts and assay of enzyme
Preparation of cell extracts and assay of enzyme was performed as previously described (Hasegawa et al., 1996) with some modi®cations (Suzuki et al., 1997a,b) . Cells were collected, washed with PBS and suspended in PBS-EDTA (pH 7.4). After the addition of 10 mM digitonin (Sigma), cells were incubated at 378C for 10 min. Lysates were collected by centrifugation (15 000 r.p.m./5 min), and total protein concentration was determined using a DC protein assay kit (Bio-Rad, CA, USA). For enzyme assay, aliquots were incubated with 10 ml DEVD-MCA, ESMD-MCA or IETD-MCA (50 mM) and the release of amino-4-methylcoumarin was monitored with a spectro¯uorometer. One unit was de®ned as the amount of enzyme required to release 0.22 nmol AMC per min at 378C.
Loading of GST-p21 into HepG2 cells
For the loading of GST-p21 proteins into HepG2 cells, the OLP loading procedure (Williams and Henkart, 1994) was used with some modi®cations (Suzuki et al., 1997a) . After the loading of GST-p21 into HepG2 cells, cells were incubated with 1 mg/ml Fas Ab for 24 h in the presence of 0.5 mg/ml actinomycin D, and death induction was examined by Hoechst 33342 staining analysis.
